Michael Edward Hagensee MD
Associate Professor, Medicine, LSU School of Medicine New Orleans
Join to View Full Profile
136 S Roman StLsuhscNew Orleans, LA 70112
Phone+1 504-903-6569
Fax+1 504-903-6842
Dr. Hagensee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Infectious Disease, 1991 - 1994- University of WashingtonResidency, Internal Medicine, 1988 - 1991
Baylor College of MedicineClass of 1988
Certifications & Licensure
LA State Medical License 1996 - 2025
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2013-2016
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- Characterization of Vaccine-Enhanced Humoral Immune Responses Against Emergent SARS-CoV-2 Variants in a Convalescent Cohort.Jared Sheehan, Amber J Trauth, Michael E Hagensee, Alistair J Ramsay
Pathogens. 2025-01-08 - 1 citationsSerum oxidative biomarkers associated with genital HPV infection and cervical lesions in women.Hui-Yi Lin, Xiaodan Zhu, Harun Or Rashid Mazumder, Martin Ronis, Kim Brint Pedersen
Journal of Medical Virology. 2024-01-01 - 7 citationsDynamics of Serum-Neutralizing Antibody Responses in Vaccinees through Multiple Doses of the BNT162b2 Vaccine.Jared Sheehan, Caleb M Ardizzone, Mayank Khanna, Amber J Trauth, Michael E Hagensee
Vaccines. 2023-11-15
Press Mentions
LSU Health New Orleans Receives $3.1 Million Grant to Study Head and Neck Cancer Incidence in People Living with HIVNovember 11th, 2024- Researchers Secure $1.5 Million Grant to Eliminate Barriers from Cervical Cancer PreventionJanuary 25th, 2024
Grant Support
- The role of antiretroviral therapy in susceptibility to oral human papillomavirus (HPV) infectionLSU HEALTH SCIENCES CENTER2024–2029
- Interaction Of EBV And HPV In The Development Of Cervical Dysplasia In HIV+ WomenNational Cancer Institute2008–2012
- Oral HPV Infection In HIV Co-Infected IndividualsNational Center For Research Resources2004–2006
- Development Of Immune Assays For HPV-32National Cancer Institute2004–2006
- Prevalence Of HPV In The Oral Cavity Of HIV+ IndividualsNational Institute Of Dental &Craniofacial Research2002–2003
- Development Of A Urine PCR Assay For HPV DNA DetectionNational Cancer Institute2000–2001
- Noninvasive Detection Of Antibodies Against HPVNational Cancer Institute1999–2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
